Traders should monitor the May 8, 2026, reconvened meeting closely. The repeated failure to achieve a quorum on a $4M market cap stock suggests potential issues with shareholder alignment or corporate communication, which could be a red flag for governance-sensitive investors. A successful vote is needed to address any pending proposals, such as director elections or executive compensation.
Price Chart
Executive Summary
iSpecimen Inc. has repeatedly failed to achieve a quorum for its 2025 Annual Meeting, adjourning the meeting multiple times since December 31, 2025. The meeting is next scheduled for May 8, 2026. This persistent inability to convene shareholders raises concerns about corporate governance and shareholder engagement.
Key Facts
- The 2025 Annual Meeting was first convened on December 31, 2025, but was immediately adjourned due to lack of a quorum.
- The meeting was reconvened and adjourned again on January 23, February 13, March 13, and April 10, 2026, for the same reason.
- The company will attempt to reconvene the meeting on May 8, 2026, with the same record date of November 3, 2025, and the same proposals.
- The company is an emerging growth company with a very small market cap of $4M.
Financial Impact
No direct financial impact from the adjournments, but the ongoing failure to hold the meeting creates significant governance risk and uncertainty.
Risk Factors
- Continued inability to achieve a quorum could lead to a governance crisis.
- The delay in holding the annual meeting may indicate deeper issues with shareholder relations or company transparency.
- The small market cap makes the stock highly susceptible to volatility if governance concerns escalate.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-042976 |
| Document: 0001213900-26-042976-index-headers.html | 0001213900-26-042976 |
| Document: 0001213900-26-042976-index.html | 0001213900-26-042976 |
| Document: 0001213900-26-042976.txt | 0001213900-26-042976 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 6w ago | 8-K | $1.47 | awaiting T+60 | — | $0.8400 (+42.86%) |
Sep 4, 2026 7w ago | 8-K | $1.59 | awaiting T+60 | — | $0.8400 (−47.17%) |
Aug 14, 2026 10w ago | 8-K | $2.15 | awaiting T+60 | — | $0.8400 (+60.93%) |
Aug 7, 2026 11w ago | 8-K | $2.24 | awaiting T+60 | — | $0.8400 (+62.50%) |
Aug 7, 2026 11w ago | 424B4 | $2.22 | awaiting T+60 | — | $0.8400 (+62.16%) |
Jul 31, 2026 12w ago | EFFECT | $1.89 $0.8398 | ▲ +55.57% | ▲ +58.02% | $0.8400 (+55.56%) |
Jul 16, 2026 14w ago | S-1/A | $2.10 $1.08 | ▲ +48.57% | ▲ +53.25% | $0.8400 (+60.00%) |
Jul 14, 2026 14w ago | 8-K | $2.23 $1.09 | ▼ −51.12% | ▼ −53.65% | $0.8400 (−62.33%) |
Jun 18, 2026 18w ago | EFFECT | $2.59 $1.47 | ▲ +43.24% | ▲ +45.14% | $0.8400 (+67.57%) |
Jun 1, 2026 21w ago | 8-K | $3.07 $1.64 | ▲ +46.58% | ▲ +47.70% | $0.8400 (+72.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers